Search

everythinglearnresearchcommunity

for

Search:↓

Oral paclitaxel plus encequidar improved tumor response and caused less neuropathy but more serious infections than intravenous paclitaxel.

A golden lion tamarin had Cushing's disease due to a pituitary tumor, leading to its euthanasia.

A toddler with a rare adrenal gland tumor causing male-like physical changes was successfully treated with surgery.

A woman with unexplained hair loss was found to have harmless skin tumors and a scarring hair loss condition, but the tumors didn't cause the hair loss.

A 10-year-old girl's symptoms improved after surgery to remove a benign adrenal tumor.

The enzymes 5α-reductase and 3α/β-hydroxysteroid oxidoreductase help create brain-active substances from progesterone and testosterone, which could be used for treatment, but more research is needed to ensure their safety and effectiveness.

Scientists created iodinated arylhydantoins and arylthiohydantoins that could potentially be used for imaging prostate cancer. Some versions with specific side-chains showed high potential for this use.

5α-reductase inhibitors can reduce prostate cancer risk but may increase high-grade tumors, needing more research.

Docetaxel is safe and works well for older people with cancer, with manageable side effects.

The European School of Oncology organized various educational events in 1994, highlighting important cancer research findings.

Fructus Malvae may help with diabetes, tumors, and hair loss due to its various active compounds.

A protein called CBP is found in prostate cancer and can increase the effectiveness of certain prostate cancer treatments.

Androgen receptors are key for development and health, affecting conditions like prostate cancer and male pattern baldness.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.

The effects of estrogen on human scalp hair growth are unclear and need more research.

A woman's mature cystic teratoma caused her virilization by producing testosterone.

Scientists at the University of Michigan Medical School successfully created a special compound that can be used to improve imaging of prostate cancer.

VHL disease can cause early paragangliomas, needing lifelong monitoring.

The document explains how certain drugs block hormones to treat cancers like breast and prostate cancer.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

An 86-year-old man with prostate cancer was diagnosed with a rare, low-grade breast cancer and underwent surgery but declined additional hormone therapy.

Tetracycline successfully treated a Labrador's skin calcification and hair loss.

Cutaneous angiosarcomas require a combined treatment approach, but prognosis is generally poor.

The new LC-MS/MS method is more accurate and reliable than traditional immunoassays for measuring steroids in serum.

Improved nutrition quickly healed the patient's skin lesions.

The conclusion suggests a new treatment for infantile hemangiomas and a potential target for hair loss treatment.

Coumarin derivatives show promise as anti-estrogenic agents for treating breast cancer, with some in clinical trials.

Some heart drugs show promise for other conditions, but more research is needed to confirm their effectiveness and safety.

Finasteride may reduce prostate cancer spread by lowering certain enzyme levels.

Basal cell carcinomas have much higher levels of Vitamin D3 receptors compared to healthy skin.